Gregory J. Gores

90.6k total citations · 30 hit papers
591 papers, 63.2k citations indexed

About

Gregory J. Gores is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Gregory J. Gores has authored 591 papers receiving a total of 63.2k indexed citations (citations by other indexed papers that have themselves been cited), including 241 papers in Surgery, 210 papers in Epidemiology and 207 papers in Hepatology. Recurrent topics in Gregory J. Gores's work include Cholangiocarcinoma and Gallbladder Cancer Studies (179 papers), Liver Disease Diagnosis and Treatment (160 papers) and Gallbladder and Bile Duct Disorders (100 papers). Gregory J. Gores is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (179 papers), Liver Disease Diagnosis and Treatment (160 papers) and Gallbladder and Bile Duct Disorders (100 papers). Gregory J. Gores collaborates with scholars based in United States, Germany and China. Gregory J. Gores's co-authors include Steven F. Bronk, Harmeet Malhi, Maria Eugenia Guicciardi, Lewis R. Roberts, Sumera I. Ilyas, Nathan W. Werneburg, Nicholas F. LaRusso, Tushar Patel, Ali Canbay and Scott H. Kaufmann and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gregory J. Gores

577 papers receiving 62.2k citations

Hit Papers

A global view of hepatoce... 1996 2026 2006 2016 2019 2016 2008 2017 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A global view of hepatocellular carcinoma: trends, risk, prevention and management
    2019 2.9k citations Ju Dong Yang, Pierre Hainaut et al. Nature Reviews Gastroenterology & Hepatology profile →
  2. Hepatocellular carcinoma
    2016 1.9k citations Gregory J. Gores et al. profile →
  3. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
    2008 1.3k citations Myron Schwartz, Gregory J. Gores et al. profile →
  4. Cholangiocarcinoma — evolving concepts and therapeutic strategies
    2017 1.1k citations Gregory J. Gores et al. profile →
  5. Hepatocellular carcinoma: clinical frontiers and perspectives
    2014 1.1k citations Gregory J. Gores et al. profile →
  6. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    2014 1.0k citations Tushar Patel, Gregory J. Gores et al. profile →
  7. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
    2013 947 citations Gregory J. Gores et al. profile →
  8. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
    2003 860 citations Keith D. Lindor, Gregory J. Gores et al. profile →
  9. Diagnosis and Management of Primary Sclerosing Cholangitis
    2009 843 citations Gregory J. Gores et al. Hepatology profile →
  10. Biliary Tract Cancers
    1999 739 citations Piet C. de Groen, Gregory J. Gores et al. profile →
  11. mir-29 regulates Mcl-1 protein expression and apoptosis
    2007 688 citations Steven F. Bronk, Gregory J. Gores et al. profile →
  12. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
    2004 655 citations Nathan W. Werneburg, Steven F. Bronk et al. Hepatology profile →
  13. Lysosomes in cell death
    2004 615 citations Gregory J. Gores et al. profile →
  14. Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
    2000 606 citations Steven F. Bronk, Gregory J. Gores et al. profile →
  15. Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
    2006 597 citations Harmeet Malhi, Steven F. Bronk et al. profile →
  16. Cholangiocarcinoma
    2008 541 citations Boris Blechacz, Gregory J. Gores Hepatology profile →
  17. Apoptosis and Necrosis in the Liver: A Tale of Two Deaths?
    2006 530 citations Harmeet Malhi, Gregory J. Gores et al. Hepatology profile →
  18. Clinical diagnosis and staging of cholangiocarcinoma
    2011 520 citations Boris Blechacz, Gregory J. Gores et al. Nature Reviews Gastroenterology & Hepatology profile →
  19. Life and death by death receptors
    2009 515 citations Gregory J. Gores et al. profile →
  20. The role of proteases during apoptosis
    1996 501 citations Tushar Patel, Gregory J. Gores et al. profile →
  21. Cholangiocarcinoma
    2021 463 citations Alphonse E. Sirica, Gregory J. Gores et al. profile →
  22. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
    2016 406 citations Petra Hirsova, Anuradha Krishnan et al. profile →
  23. Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
    2012 351 citations Denise M. Harnois, Charles B. Rosen et al. profile →
  24. Cholangiocyte pathobiology
    2019 339 citations Tom H. Karlsen, Nicholas F. LaRusso et al. Nature Reviews Gastroenterology & Hepatology profile →
  25. Systemic therapies for intrahepatic cholangiocarcinoma
    2020 271 citations Gregory J. Gores et al. profile →
  26. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
    2022 269 citations Gregory J. Gores et al. profile →
  27. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
    2018 221 citations Alphonse E. Sirica, Gregory J. Gores et al. Hepatology profile →
  28. TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
    2021 163 citations Gregory J. Gores et al. profile →
  29. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
    2023 147 citations Gregory J. Gores et al. profile →
  30. Cholangiocarcinoma — novel biological insights and therapeutic strategies
    2023 94 citations Silvia Affò, Ju Dong Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory J. Gores United States 142 23.6k 20.1k 19.3k 19.0k 14.2k 591 63.2k
Josep M. Llovet Spain 116 15.5k 0.7× 31.2k 1.6× 19.1k 1.0× 55.9k 2.9× 16.4k 1.2× 357 85.2k
Jordi Bruix Spain 103 14.7k 0.6× 34.0k 1.7× 12.5k 0.6× 56.4k 3.0× 11.5k 0.8× 380 75.1k
Scott L. Friedman United States 119 9.6k 0.4× 32.5k 1.6× 18.1k 0.9× 30.7k 1.6× 6.1k 0.4× 438 61.8k
Yoshihiko Maehara Japan 92 14.4k 0.6× 6.2k 0.3× 11.2k 0.6× 8.7k 0.5× 13.5k 1.0× 1.7k 42.9k
David A. Brenner United States 132 9.0k 0.4× 26.8k 1.3× 20.1k 1.0× 22.0k 1.2× 5.0k 0.4× 517 59.5k
Peter Schirmacher Germany 86 6.8k 0.3× 9.2k 0.5× 10.9k 0.6× 10.6k 0.6× 11.6k 0.8× 681 36.7k
Kazuaki Chayama Japan 99 10.7k 0.5× 15.7k 0.8× 7.5k 0.4× 14.9k 0.8× 7.4k 0.5× 1.4k 45.3k
Jia Fan China 97 5.8k 0.2× 6.5k 0.3× 16.9k 0.9× 8.7k 0.5× 12.3k 0.9× 820 39.3k
Lewis R. Roberts United States 76 6.6k 0.3× 9.7k 0.5× 9.4k 0.5× 13.3k 0.7× 6.3k 0.4× 428 29.4k
David E. Kleiner United States 100 7.3k 0.3× 32.1k 1.6× 8.0k 0.4× 17.6k 0.9× 6.8k 0.5× 515 50.7k

Countries citing papers authored by Gregory J. Gores

Since Specialization
Citations

This map shows the geographic impact of Gregory J. Gores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Gores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Gores more than expected).

Fields of papers citing papers by Gregory J. Gores

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Gores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Gores. The network helps show where Gregory J. Gores may publish in the future.

Co-authorship network of co-authors of Gregory J. Gores

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Gores. A scholar is included among the top collaborators of Gregory J. Gores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Gores. Gregory J. Gores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fritcher, Emily G. Barr, Dragana Milosevic, Michael J. Levy, et al.. (2024). Utility of methylated DNA markers for the diagnosis of malignant biliary strictures. Hepatology. 81(2). 453–464. 2 indexed citations
2.
Affò, Silvia, Aveline Filliol, Gregory J. Gores, & Robert F. Schwabe. (2023). Fibroblasts in liver cancer: functions and therapeutic translation. ˜The œLancet. Gastroenterology & hepatology. 8(8). 748–759. 23 indexed citations
3.
Buckarma, EeeLN H., Jennifer A. Yonkus, Nathan W. Werneburg, et al.. (2022). SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models. JCI Insight. 7(15). 12 indexed citations
4.
Caldera, Freddy, Francis A. Farraye, Brian M. Necela, et al.. (2022). Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflammatory Bowel Diseases. 29(8). 1202–1209. 11 indexed citations
5.
Mousa, Omar Y., Brian D. Juran, Bryan M. McCauley, et al.. (2020). Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. Hepatology. 74(1). 281–295. 68 indexed citations
6.
Yang, Ju Dong, Pierre Hainaut, Gregory J. Gores, et al.. (2019). A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology. 16(10). 589–604. 2931 indexed citations breakdown →
7.
Roddy, Gavin W., Robert H. Rosa, Kimberly Viker, et al.. (2019). Diet Mimicking “Fast Food” Causes Structural Changes to the Retina Relevant to Age-Related Macular Degeneration. Current Eye Research. 45(6). 726–732. 26 indexed citations
8.
Sugihara, Takaaki, Nathan W. Werneburg, Matthew C. Hernandez, et al.. (2018). YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity. Molecular Cancer Research. 16(10). 1556–1567. 84 indexed citations
9.
Yang, Ju Dong, Jianliang Dai, Amit G. Singal, et al.. (2017). Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1085–1092. 45 indexed citations
10.
Chaiteerakij, Roongruedee, William S. Harmsen, Terry M. Therneau, et al.. (2014). A New Clinically Based Staging System for Perihilar Cholangiocarcinoma. The American Journal of Gastroenterology. 109(12). 1881–1890. 75 indexed citations
11.
Terzic, André, C. Michel Harper, Gregory J. Gores, & Michael Pfenning. (2013). Regenerative Medicine Blueprint. Stem Cells and Development. 22(1_suppl). 20–24. 17 indexed citations
12.
Mertens, Joachim C., Christian D. Fingas, John D. Christensen, et al.. (2012). Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma. Cancer Research. 73(2). 897–907. 158 indexed citations
13.
Moreno-Luna, Laura E., Ju Dong Yang, William Sánchez, et al.. (2012). Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 36(3). 714–723. 113 indexed citations
14.
Smoot, Rory L., Boris Blechacz, Nathan W. Werneburg, et al.. (2010). A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells. Cancer Research. 70(5). 1960–1969. 43 indexed citations
15.
Björnsson, Einar, Felicity Enders, Emily G. Barr Fritcher, et al.. (2009). Long-Term Outcomes of Positive Fluorescence in Situ Hybridization Tests in Primary Sclerosing Cholangitis. Hepatology. 51(1). 174–180. 126 indexed citations
16.
Rosen, Charles B., Julie K. Heimbach, & Gregory J. Gores. (2007). Current status of liver transplantation for hilar cholangiocarcinoma. Current Opinion in Organ Transplantation. 12(3). 215–219. 1 indexed citations
17.
Malhi, Harmeet, Gregory J. Gores, & John J. Lemasters. (2006). Apoptosis and Necrosis in the Liver: A Tale of Two Deaths?. Hepatology. 43(Supplement 1). S31–S44. 530 indexed citations breakdown →
18.
Hassoun, Ziad & Gregory J. Gores. (2003). Treatment of hepatocellular carcinoma. Clinical Gastroenterology and Hepatology. 1(1). 10–18. 30 indexed citations
19.
Jaeschke, Hartmut, et al.. (2001). FORUM Mechanisms of Hepatotoxicity. 3 indexed citations
20.
Patel, Tushar, Clifford J. Steer, & Gregory J. Gores. (1999). Apoptosis and the liver: A mechanism of disease, growth regulation, and carcinogenesis. Hepatology. 30(3). 811–815. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep M. Llovet Breakdown of academic impact, for papers by Jordi Bruix Breakdown of academic impact, for papers by Scott L. Friedman Breakdown of academic impact, for papers by Yoshihiko Maehara Breakdown of academic impact, for papers by David A. Brenner Breakdown of academic impact, for papers by Peter Schirmacher Breakdown of academic impact, for papers by Kazuaki Chayama Breakdown of academic impact, for papers by Jia Fan Breakdown of academic impact, for papers by Lewis R. Roberts Breakdown of academic impact, for papers by David E. Kleiner
Rankless by CCL
2026